Msefsl

CLOSE X

Risk Disclosures on Derivatives

>9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
>On an average, loss makers registered net trading loss close to ₹ 50,000.
>Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
>Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.

ASSTON PHARMACEUTICALS LTD.

NSE : NABSE : 544445ISIN CODE : INE0SJX01015Industry : Pharmaceuticals & DrugsHouse : Private

BSE123.95-1 (-0.8 %)

PREV CLOSE ( ) 124.95

OPEN PRICE ( ) 124.00

BID PRICE (QTY) 0.00 (0)

OFFER PRICE (QTY) 0.00 (0)

VOLUME 149000

TODAY'S LOW / HIGH ( )120.00 125.00

52 WK LOW / HIGH ( ) 113.05124.95

NSE

This Company is not listed in NSE

BSE NSE

1D 1M 3M 1Y 3Y 5Y

STOCK SUMMARY

Incorporation Year : 16-04 2019

Management Info

- Chairman Ashish Narayan Sakalkar - Managing Director

Registered Office

Address 4th Floor, Office No A-431,Balaji Bhavan, Plot No 42 A,Sector-11 Cbd Belapur, Navi Mumbai,
Thane,
Maharashtra-400614

Phone 022 49731419 / 49731411

Email info@asstonpharmaceuticals.com

Website www.asstonpharmaceuticals.com

Registrars Details

Maashitla Securities Pvt Ltd.

451, Krishna Apra Business,Square, Netaji Subhash Place,,Pitampura,New Delhi

Listing : BSE

NEWS

15Jul New Listing
Notice No. 20250715-53 Notice Date 15 Jul 2025Category Company r..

08Jul Asston Pharmaceuticals coming with IPO
Asston PharmaceuticalsAsston Pharmaceuticals is coming out with an initi..

Financials

Rs. in Millions

	QTR	ANNUAL
Net Profit
Gross Profit
Operating Profit
Net Sales

ROLLING FORWARD P/E (EOD)

EVENT CALENDAR

peer group

Astrazeneca Pharma I (BSE) 9374.00 (2.30%)	M.Cap ( in Cr)23435.00
Neuland Laboratories (BSE) 14492.60 (0.65%)	M.Cap ( in Cr)18593.84
Hester Biosciences (BSE) 1946.45 (4.57%)	M.Cap ( in Cr)1655.82
Concord Biotech (BSE) 1918.00 (4.36%)	M.Cap ( in Cr)20065.39
Cohance Lifesciences (BSE) 1120.00 (5.42%)	M.Cap ( in Cr)42847.52

Shareholding Pattern

No Data Found

Mf Holdings

Scheme Name	Hold(%)
No Data Found

Risk Disclosures on Derivatives

Smart Quotes

ASSTON PHARMACEUTICALS LTD.